telmisartan has been researched along with Injury, Ischemia-Reperfusion in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Gaber, SA; Abdelzaher, WY; Mohammed, MM; Morsy, MA; Nair, AB; Rifaai, RA | 1 |
| Abdel-Fattah, MM; Mansour, AM; Messiha, BAS | 1 |
| Cardona-Muñoz, EG; Castillo-Romero, A; García-Benavides, L; Garcia-Cobián, TA; Miranda-Díaz, AG; Ramírez-Lizardo, EJ; Rodríguez-Lara, SQ; Totsuka-Sutto, SE; Trujillo-Rangel, WA | 1 |
| Abe, K; Deguchi, K; Hishikawa, N; Kurata, T; Morimoto, N; Ohta, Y; Yamashita, T; Zhai, Y | 1 |
| Akcilar, R; Aras, B; Bayat, Z; Kocak, C; Kocak, FE; Metineren, MH; Simsek, H; Yucel, M | 1 |
| Alhusseini, NF; Ali, SI; Atteia, HH; Hasan, RA; Idris, RA | 1 |
| Altunkaynak, Z; Gocer, F; Halici, MB; Karaca, M; Keles, ON; Kumtepe, Y; Odabasoglu, F; Polat, B | 1 |
| Fujiwara, M; Haraguchi, T; Hayakawa, K; Iwasaki, K; Katsurabayashi, S; Mishima, K; Naito, T; Takasaki, K | 1 |
| Al-Melhim, WN; Al-Sultan, AI; Fouad, AA; Qureshi, HA; Yacoubi, MT | 1 |
| Hirose, H; Kasahara, Y; Matsuyama, T; Nakagomi, T; Nakano, A; Stern, DM; Taguchi, A; Uno, H | 1 |
| Bhalodia, Y; Jivani, N; Sheth, N; Vaghasiya, J | 1 |
| Tawfik, MK | 1 |
| Boku, N; Eto, M; Kajihara, N; Morita, S; Nishida, T; Tatewaki, H | 1 |
13 other study(ies) available for telmisartan and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Protective mechanisms of telmisartan against hepatic ischemia/reperfusion injury in rats may involve PPARγ-induced TLR4/NF-κB suppression.
Topics: Alanine Transaminase; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartate Aminotransferases; Caspase 3; Cytokines; Liver; Male; NF-kappa B; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Telmisartan; Toll-Like Receptor 4 | 2022 |
Modulation of brain ACE and ACE2 may be a promising protective strategy against cerebral ischemia/reperfusion injury: an experimental trial in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Brain; Brain Ischemia; Cytokines; Glutathione; Male; Malondialdehyde; Nitric Oxide; Peptidyl-Dipeptidase A; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Telmisartan; Xanthenes | 2018 |
Effect of Telmisartan in the Oxidative Stress Components Induced by Ischemia Reperfusion in Rats.
Topics: Animals; Antihypertensive Agents; Humans; Ischemia; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Telmisartan | 2019 |
Strong improvement of apolipoprotein E/low-density lipoprotein receptor signals by telmisartan in poststroke spontaneously hypertensive stroke resistant.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Benzimidazoles; Benzoates; Cerebral Cortex; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Male; Mitogen-Activated Protein Kinase 1; Rats; Rats, Inbred SHR; Receptors, LDL; Reperfusion Injury; Signal Transduction; Stroke; Telmisartan | 2014 |
Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Animals; Antioxidants; Apoptosis; Arginine; Benzimidazoles; Benzoates; Captopril; Creatine; Endothelin-1; Gene Expression Regulation; Glutathione Peroxidase; Ischemia; Kidney; Lipocalin-2; Lipocalins; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oleanolic Acid; Proto-Oncogene Proteins; Rats; Rats, Wistar; Reperfusion Injury; Sulfhydryl Compounds; Superoxide Dismutase; Telmisartan; Urea | 2016 |
Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats.
Topics: Acute Kidney Injury; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Garlic; Kidney; Obesity; Rats; Reperfusion Injury; Telmisartan | 2016 |
Protective effects of telmisartan on ischemia/reperfusion injury of rat ovary: biochemical and histopathologic evaluation.
Topics: Animals; Antioxidants; Benzimidazoles; Benzoates; Disease Models, Animal; Female; Nitric Oxide Synthase Type II; Ovary; Oxidative Stress; Peroxidase; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Telmisartan | 2010 |
Cerebroprotective action of telmisartan by inhibition of macrophages/microglia expressing HMGB1 via a peroxisome proliferator-activated receptor gamma-dependent mechanism.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Benzoates; Cerebral Cortex; HMGB1 Protein; Ischemic Attack, Transient; Macrophages; Male; Mice; Microglia; Neuroprotective Agents; PPAR gamma; Reperfusion Injury; Telmisartan | 2009 |
Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzimidazoles; Benzoates; Blood Pressure; Blood Urea Nitrogen; Caspase 3; Catalase; Creatinine; Disease Models, Animal; Glutathione; Homocysteine; Kidney; Kidney Diseases; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Superoxide Dismutase; Telmisartan; Tumor Necrosis Factor-alpha | 2010 |
Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Gliosis; Inflammation Mediators; Male; Mice; Mice, SCID; Nerve Degeneration; Neuroprotective Agents; PPAR gamma; Receptor, Angiotensin, Type 1; Reperfusion Injury; Telmisartan | 2010 |
Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Drug Therapy, Combination; Fenofibrate; Homocysteine; Hypolipidemic Agents; Kidney; Kidney Function Tests; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Telmisartan | 2010 |
Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glutathione; Hypoglycemic Agents; Inflammation Mediators; Kidney; Lipid Peroxidation; Lipid Peroxides; Oxidative Stress; Pioglitazone; Rats; Reperfusion Injury; Superoxide Dismutase; Telmisartan; Thiazolidinediones; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
Angiotensin II type 1 receptor antagonist protects ventricular and coronary endothelial function after 24-hour heart preservation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Coronary Vessels; Creatine Kinase; Endothelium; Heart Transplantation; Hypothermia, Induced; Nitric Oxide; Rabbits; Receptor, Angiotensin, Type 1; Regional Blood Flow; Reperfusion Injury; Telmisartan; Vasodilation; Ventricular Function | 2005 |